Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Not yet recruiting 3Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gynecologic 1CNS 1

Conditions

Sleep Initiation and Maintenance Disorders 1Breast Neoplasms 1Breast Cancer Surgery 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Esketamine × Breast × Clear all
NCT05732064 2025-07-31

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Peking University First Hospital

Phase 4 Completed
180 enrolled
Breast

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

NCT05060068 2024-08-06

Effect of Intravenous S-ketamine on Opioid Consumption

The Second Hospital of Anhui Medical University

Phase NA Completed
345 enrolled
Breast

Breast Cancer Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡